Carey E. Gleason, PhD Print Friendly PageFaculty, University of Wisconsin School of Medicine and Public Health
Carey E. Gleason, PhD completed her education at the California School of Professional Psychology.
UW Health Clinics
UW School of Medicine and Public Health
|Department of Medicine|
Professional Certifications and Education
California School of Professional Psychology, Fresno
Geropsychology Fellowship, Loius Stokes Cleveland Veterans Administrations Medical Center, Cleveland, OH; Neuropsychology Fellowship; University of Washington, Geriatric Research, Education and Clinical Center (GRECC), Tacoma, WA
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
Almeida RP Schultz SA Austin BP Boots EA Dowling NM Gleason CE Bendlin BB Sager MA Hermann BP Zetterberg H Carlsson CM Johnson SC Asthana S Okonkwo OC .
Effect of Cognitive Reserve on Age-Related Changes in Cerebrospinal Fluid Biomarkers of Alzheimer Disease. JAMA Neurol. 2015 Apr 20;
[PubMed ID: 25893879]
Starks EJ O'Grady JP Hoscheidt SM Racine AM Carlsson CM Zetterberg H Blennow K Okonkwo OC Puglielli L Asthana S Dowling NM Gleason CE Anderson RM Davenport-Sis NJ DeRungs LM Sager MA Johnson SC Bendlin BB .
Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOE ε4 Carriers. J Alzheimers Dis. 2015 Mar 26;
[PubMed ID: 25812851]
Dowling NM Johnson SC Gleason CE Jagust WJ .
The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function. Neuroimage. 2015 Jan 15;105:357-68
[PubMed ID: 25450107]
Mielke MM Haughey NJ Bandaru VV Zetterberg H Blennow K Andreasson U Johnson SC Gleason CE Blazel HM Puglielli L Sager MA Asthana S Carlsson CM .
Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease. Neurobiol Aging. 2014 Nov;35(11):2486-94
[PubMed ID: 24952994]
Fischer B Gleason C Asthana S .
Effects of hormone therapy on cognition and mood. Fertil Steril. 2014 Apr;101(4):898-904
[PubMed ID: 24680649]
Fischer BL Gleason CE Gangnon RE Janczewski J Shea T Mahoney JE .
Declining cognition and falls: role of risky performance of everyday mobility activities. Phys Ther. 2014 Mar;94(3):355-62
[PubMed ID: 24231226]
Wharton W Gleason CE Dowling NM Carlsson CM Brinton EA Santoro MN Neal-Perry G Taylor H Naftolin F Lobo RA Merriam G Manson JE Cedars MI Miller VM Black DM Budoff M Hodis HN Harman SM Asthana S .
The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition. J Alzheimers Dis. 2014;40(2):331-41
[PubMed ID: 24430001]
Fischer BL Hoyt WT Maucieri L Kind AJ Gunter-Hunt G Swader TC Gangnon RE Gleason CE .
Performance-based assessment of falls risk in older veterans with executive dysfunction. J Rehabil Res Dev. 2014;51(2):263-74
[PubMed ID: 24933724]
Dowling NM Gleason CE Manson JE Hodis HN Miller VM Brinton EA Neal-Perry G Santoro MN Cedars M Lobo R Merriam GR Wharton W Naftolin F Taylor H Harman SM Asthana S .
Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance. PLoS One. 2013;8(7):e68741
[PubMed ID: 23874743]
Wharton W Gleason CE Miller VM Asthana S .
Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS Cognitive and Affective sub study (KEEPS Cog). Brain Res. 2013 Jun 13;1514:12-7
[PubMed ID: 23603409]
Egan KR Gleason CE .
Longer duration of hormonal contraceptive use predicts better cognitive outcomes later in life. J Womens Health (Larchmt). 2012 Dec;21(12):1259-66
[PubMed ID: 22994984]
Wharton W Gleason CE Olson SR Carlsson CM Asthana S .
Neurobiological Underpinnings of the Estrogen - Mood Relationship. Curr Psychiatry Rev. 2012 Aug 1;8(3):247-256
[PubMed ID: 23990808]
Gleason CE Dowling NM Friedman E Wharton W Asthana S .
Using predictors of hormone therapy use to model the healthy user bias: how does healthy user status influence cognitive effects of hormone therapy? Menopause. 2012 May;19(5):524-33
[PubMed ID: 22207317]
Dowling NM Olson N Mish T Kaprakattu P Gleason C .
A model for the design and implementation of a participant recruitment registry for clinical studies of older adults. Clin Trials. 2012 Apr;9(2):204-14
[PubMed ID: 22273586]
Wharton W Stein JH Korcarz C Sachs J Olson SR Zetterberg H Dowling M Ye S Gleason CE Underbakke G Jacobson LE Johnson SC Sager MA Asthana S Carlsson CM .
The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial. J Alzheimers Dis. 2012;32(1):147-56
[PubMed ID: 22776970]
Wharton W Baker LD Gleason CE Dowling M Barnet JH Johnson S Carlsson C Craft S Asthana S .
Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial. J Alzheimers Dis. 2011;26(3):495-505
[PubMed ID: 21694454]
Lin F Wharton W Dowling NM Ries ML Johnson SC Carlsson CM Asthana S Gleason CE .
Awareness of memory abilities in community-dwelling older adults with suspected dementia and mild cognitive impairment. Dement Geriatr Cogn Disord. 2010;30(1):83-92
[PubMed ID: 20714155]
Wharton W Dowling M Khosropour CM Carlsson C Asthana S Gleason CE .
Cognitive benefits of hormone therapy: cardiovascular factors and healthy-user bias. Maturitas. 2009 Nov 20;64(3):182-7
[PubMed ID: 19879073]
Gleason CE Carlsson CM Barnet JH Meade SA Setchell KD Atwood CS Johnson SC Ries ML Asthana S .
A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women. Age Ageing. 2009 Jan;38(1):86-93
[PubMed ID: 19054783]
Gleason CE Gangnon RE Fischer BL Mahoney JE .
Increased risk for falling associated with subtle cognitive impairment: secondary analysis of a randomized clinical trial. Dement Geriatr Cogn Disord. 2009;27(6):557-63
[PubMed ID: 19602883]